Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Interest & Investment Income (2017 - 2025)

Puma Biotechnology (PBYI) has disclosed Interest & Investment Income for 9 consecutive years, with $977000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest & Investment Income fell 20.31% year-over-year to $977000.0, compared with a TTM value of $4.1 million through Dec 2025, down 13.67%, and an annual FY2025 reading of $4.1 million, down 13.67% over the prior year.
  • Interest & Investment Income was $977000.0 for Q4 2025 at Puma Biotechnology, down from $1.0 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $1.3 million in Q3 2024 and bottomed at $13000.0 in Q1 2021.
  • Average Interest & Investment Income over 5 years is $619000.0, with a median of $674500.0 recorded in 2023.
  • The sharpest move saw Interest & Investment Income plummeted 96.63% in 2021, then surged 4030.77% in 2023.
  • Year by year, Interest & Investment Income stood at $13000.0 in 2021, then skyrocketed by 3892.31% to $519000.0 in 2022, then skyrocketed by 38.54% to $719000.0 in 2023, then surged by 70.51% to $1.2 million in 2024, then decreased by 20.31% to $977000.0 in 2025.
  • Business Quant data shows Interest & Investment Income for PBYI at $977000.0 in Q4 2025, $1.0 million in Q3 2025, and $956000.0 in Q2 2025.